KETAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ketamine Hydrochloride, and what generic alternatives are available?
Ketamine Hydrochloride is a drug marketed by Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, and Hospira. and is included in five NDAs.
The generic ingredient in KETAMINE HYDROCHLORIDE is ketamine hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the ketamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ketamine Hydrochloride
A generic version of KETAMINE HYDROCHLORIDE was approved as ketamine hydrochloride by HIKMA on March 22nd, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KETAMINE HYDROCHLORIDE?
- What are the global sales for KETAMINE HYDROCHLORIDE?
- What is Average Wholesale Price for KETAMINE HYDROCHLORIDE?
Summary for KETAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 54 |
| Clinical Trials: | 1,252 |
| Patent Applications: | 2,773 |
| DailyMed Link: | KETAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for KETAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Brian Anderson, MD | Phase 4 |
| University Hospital, Basel, Switzerland | Phase 1 |
| Jay Fournier | Phase 1/Phase 2 |
Pharmacology for KETAMINE HYDROCHLORIDE
| Drug Class | General Anesthetic |
| Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for KETAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for KETAMINE HYDROCHLORIDE
US Patents and Regulatory Information for KETAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | KETAMINE HYDROCHLORIDE | ketamine hydrochloride | INJECTABLE;INJECTION | 076092-001 | Sep 30, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Gland Pharma Ltd | KETAMINE HYDROCHLORIDE | ketamine hydrochloride | INJECTABLE;INJECTION | 216809-002 | Jan 24, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | KETAMINE HYDROCHLORIDE | ketamine hydrochloride | INJECTABLE;INJECTION | 215808-001 | Jan 13, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
